Bibliography
- Deng XQ, Song MX, Wei CX, et al. Synthesis and anticonvulsant activity of 7-alkoxy-triazolo-[3, 4-b]benzo[d] thiazoles. Med Chem 2010;6:313-20
- Amnerkar ND, Bhusari KP. Synthesis, anticonvulsant activity and 3D-QSAR study of some prop-2-eneamido and 1-acetyl-pyrazolin derivatives of aminobenzothiazole. Eur J Med Chem 2010;45:149-59
- Sreenivasa GM, Jayachandran E, Shivakumar B, et al. Synthesis of bioactive molecule fluoro benzothiazole comprising potent heterocyclic moieties for anthelmentic activity. Arch. Pharm. Res. 2009;1:150-7
- Choi MM, Kim EA, Hahn HG, et al. Protective effect of benzothiazole derivative KHG21834 on amyloid beta-induced neurotoxicity in PC12 cells and cortical and mesencephalic neurons. Toxicology 2007;239:156-66
- Jimonet P, Audiau F, Barreau M, et al. Riluzole series. Synthesis and in vivo "antiglutamate" activity of 6-substituted-2-benzothiazolamines and 3-substituted-2-imino-benzothiazolines. J Med Chem 1999;42:2828-43
- Bowyer PW, Gunaratne RS, Grainger M, et al. Molecules incorporating a benzothiazole core scaffold inhibit the N-myristoyltransferase of Plasmodium falciparum. Biochem J 2007;408:173-80
- Huang Q, Mao J, Wan B, et al. Searching for new cures for tuberculosis: design, synthesis, and biological evaluation of 2-methylbenzothiazoles. J Med Chem 2009;52:6757-67
- Al-Tel TH, Al-Qawasmeh RA, Zaarour R. Design, synthesis and in vitro antimicrobial evaluation of novel Imidazo [1,2-a]pyridine and imidazo[2,1-b][1,3]benzothiazole motifs. Eur J Med Chem 2011;46:1874-81
- Lee YR, Jin GH, Lee SM, et al. Inhibition of TNF-alpha-mediated inflammatory responses by a benzodioxolylacetylamino-linked benzothiazole analog in human fibroblast-like synoviocytes. Biochem Biophys Res Commun 2011;408:625-9
- Kamal A, Srikanth YV, Naseer Ahmed Khan M, et al. 2-Anilinonicotinyl linked 2-aminobenzothiazoles and [1,2,4]triazolo[1,5-b] [1,2,4]benzothiadiazine conjugates as potential mitochondrial apoptotic inducers. Bioorg Med Chem 2011;23:7136-50
- Kamal A, Reddy KS, Khan MN, et al. Synthesis, DNA-binding ability and anticancer activity of benzothiazole/benzoxazole-pyrrolo[2,1-c][1,4]benzodiazepine conjugates. Bioorg Med Chem 2010;18:4747-61
- Tasler S, Muller O, Wieber T, et al. Substituted 2-arylbenzothiazoles as kinase inhibitors: hit-to-lead optimization. Bioorg Med Chem 2009;17:6728-37
- Mortimer CG, Wells G, Crochard JP, et al. Antitumour benzothiazoles. 26.(1) 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines. J Med Chem 2006;49:179-85
- Cao D-X, Fang Q, Wang D, et al. Synthesis and two-photon-excited fluorescence of benzothiazole-based compounds with various pi-electron donors. Eur J Org Chem 2003;18:3628-36
- Hrobarikova V, Hrobarik P, et al. Benzothiazole-based fluorophores of donor-pi-acceptor-pi-donor type displaying high two-photon absorption. J Org Chem 2010;75:3053-68
- Sharma PC, Sinhmar A, Sharma A, et al. Medicinal significance of benzothiazole scaffold: an insight view. J Enzyme Inhib Med Chem 2013;28:240-66
- Zarate CAJr, Payne JL, Quiroz J, et al. An open-label trial of riluzole in patients with treatment-resistant major depression. Am J Psychiatry 2004;161:171-4
- Carvalho VF, Barreto EO, Serra MF, et al. Aldose reductase inhibitor zopolrestat restores allergic hyporesponsiveness in alloxan-diabetic rats. Eur J pharmacol 2006;549:173-8
- Hutchinson I, Jennings SA, Vishnuvajjala BR, et al. Antitumour benzothiazoles. 16. Synthesis and pharmaceutical properties of antitumour 2-(4-aminophenyl)benzothiazole amino acid prodrugs. J Med Chem 2002;45:744-77
- Yates PC, Mccall CJ, Stevens MFG. Structural studies on benxothiazoles. Crystal and molecular structure of 5,6-dimethoxy-Z-(4-methoxyphenyl)-benzothiazole and molecular orbital calculations on related compounds. Tetrahedron 1991;47:6493-502
- Stevens MF, McCall CJ, Lelieveld P, et al. Structural studies on bioactive compounds. 23. Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetin. J Med Chem 1994;37:1689-95
- Shi DF, Bradshaw TD, Wrigley S, et al. Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo. J Med Chem 1996;39:3375-84
- Bradshaw TD, Stevens MF, Westwell AD. The discovery of the potent and selective antitumour agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203) and related compounds. Curr Med Chem 2001;8:203-10
- Brantley E, Trapani V, Alley MC, et al. Fluorinated 2-(4-amino-3-methylphenyl) benzothiazoles induce CYP1A1 expression, become metabolized, and bind to macromolecules in sensitive human cancer cells. Drug Metab Dispos 2004;32:1392-401
- Rye HS, Yue S, Wemmer DE, et al. Stable fluorescent complexes of double-stranded DNA with bis-intercalating asymmetric cyanine dyes: properties and applications. Nucleic Acids Res 1992;20:2803-12
- Facchinetti V, da Reis R, Gomes CRB, et al. Chemistry and biological activities of 1,3-benzothiazoles. Mini Rev Org Chem 2012;9:44-53
- Bondock S, Fadaly W, Metwally MA. Recent trends in the chemistry of 2-aminobenzothiazoles. J Sulfur Chem 2009;30:74-107
- Kurtz JE, Ray-Coquard I. PI3 kinase inhibitors in the clinic: an update. Anticancer Res 2012;32:2463-70
- Swinnen D, Jorand-Lebrun C, Grippi-Vallotton T, et al. Fused bicyclic derivatives as PI3 kinase inhibitors and their preparation and use for the treatment of diseases. WO100144; 2010
- Li Y, Mei L, Li H, et al. Predation of 2-methoxy-3-substituted-sulfonylamino-5-(2-acetamido-6-benzothiazole)-benzamide derivatives as antitumor agents. CN103772317; 2014
- Gentile A, Trusolino L, Comoglio PM. The Met tyrosine kinase receptor in development and cancer. Cancer Metastasis Rev 2008;27:85-94
- Bacque E, Damour D, Nemececk C, et al. Preparation of imidazo[1,2-a]pyrimidine derivatives as c-Met inhibitors and their pharmaceutical compositions. WO007318; 2010
- Nemececk C, Ugolini A, Wentzler S. Preparation of 6-(6-O-substituted-triazolopyridazinesulfanyl) benzothiazole and benzimidazole derivatives as c-Met inhibitors and their pharmaceutical compositions. WO0089507; 2010
- Damour D. Preparation of 6-[(6-alkyl- or 6-cycloalkyl-triazolopyridazin-3-yl)sulfanyl]-1,3-benzothiazole derivatives as c-Met inhibitors and their pharmaceutical compositions. WO121223; 2011
- Li X, Ma L, Zhao J, et al. Preparation of mercapto benzothiazole derivatives as antitumor agents. CN103435574; 2013
- Hong SH, Hong IS, Han EJ, Lee GH. Preparation of benzothiazole derivatives for the treatment of cancer. KR128693; 2013
- Chen Z, Su W, Shi X, Jiang L. Method for preparation of 2-(1,3-disubstituted phenyl-4-pyrazolyl)benzothiazoles and application as antitumor agent. CN101759694; 2010
- Zou Q, Liu Y, Zhengwei Y, et al. Preparation of heterocycles as protein kinase inhibitors. WO127345; 2013
- Panicker B, Oehlen LJWM, Tarrant JG, et al. Preparation of benzo[d]thiazole compounds as cytochrome P450 inhibitors and therapeutic uses thereof. WO153192; 2011
- Kamal A, Reddy CR, Prabhakar S. Imidazolylphenyl)benzothiazole derivatives as anticancer agents and process for the preparation thereof. WO110959; 2012
- Kamal A, Reddy CR, Prabhakar S. 2-Phenyl benzothlazole linked imidazole compounds as potential anticancer agents. INDE00392; 2014
- Feng Y, Lograsso P, Schroeter T, Yin Y. Preparation of benzo[d]oxazoles and benzo[d]thiazoles as kinase inhibitor. WO024903; 2010
- Jackson PF, Maharoof USM, Leonard KA, et al. Preparation of benzothiazolyl inhibitors of pro-matrix metalloproteinase activation. WO162463; 2012
- Li X, Liu X, Wang C, et al. 2-(4-Aminophenyl)benzothiazole-containing naphthalimide derivatives useful in treatment of cancers and their preparation. CN103450176; 2013
- Tang JCO, Chan ASC, Lam KH, et al. Preparation of methylcantharimide derivatives as antitumor agents. US8344007; 2013
- Hur Y, Lee HJ, Kim EK, et al. Imide-containing benzothiazole derivatives and pharmaceutical composition comprising the same. WO043002; 2013
- Kamal A, Srikanth YV, Naseer Ahmed Khan M, et al. Benzothiazole derivatives as potential anticancer agents and apoptosis inducers and process for the preparation thereof. WO111016; 2012
- Kamal A, Srikanth YV, Naseer Ahmed Khan M, et al. Benzothiazole derivatives as potential anticancer agents and apoptosis inducers and process for the preparation thereof. INDE00373; 2012
- Xue W, He Y, Chen Q, et al. Preparation of N-(2-(substituted benzothiazole-2-carbamoyl)-phenyl)-benzamide derivatives as antiphytoviral and antitumor agents. CN102391207; 2012
- Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature 2002;417:949-54
- Okaniwa M, Takagi T. Preparation of benzothiazole derivatives as anticancer agents. WO064722; 2010
- Wang L, Doherty G, Wang X, et al. Preparation of substituted benzothiazoles as apoptosis-inducing agents for the treatment of cancer, immune and autoimmune diseases. WO055895; 2013
- Han SB, Nam NH, Hue VT, et al. Preparation of hydroxamic acid compounds as histone deacetylase inhibitors and potent anticancer agents. KR132657; 2012
- Apuy JL, Inski DE, James JK. Preparation of imidazobenzothiazoles as modulators of protein kinase. WO054058; 2010
- Bhagwat SS. Preparation of imidazo[2,1-b][1,3]benzothiazole derivatives for treatment of proliferative diseases. WO056764; 2011
- Kodama T, Tanaka T, Kawamura T, et al. Pr-set7 inhibitor and therapeutic and/or preventive agent for cancer or life style-related disease. WO010715; 2011
- Malik JK, Nanjwade BK, Noolvi MN, et al. Novel diaryl substituted imidazo[2,1-b]benzothiazole derivatives, process for their preparation, and their pharmacological evaluation. INMU02510; 2011
- Su TL, Chou TC, Lee TC. Synthesis of 4H-benzo[d]pyrrolo[1,2-a]thiazoles and indolizino[6,7-b]indole derivatives as antitumor therapeutic agents. US0178629; 2013
- Kamal A, Rajesh VC, Reddy KS, et al. Preparation of pyrrolo[2,1-c][1,4]benzodiazepine-benzothiazole or -benzoxazole conjugates linked through piperazine moiety for use in treating cancer. WO117882; 2011
- Kamal A, Mallareddy A, Suresh P, et al. Benzothiazole hybrids useful as anticancer agents and process for the preparation thereof. WO104875; 2012
- Kamal A, Mallareddy A, Suresh P, et al. Benzothiazole hybrids useful as anticancer agents and process for the preparation thereof. INDE00270; 2011
- Wang JJ, Liao CC, Hu WP, Shen HC. Synthesis of 2-(4-aminophenyl)benzothiazole derivatives and use thereof. US0215154; 2012
- Kamal A, Hussaini SMA, Faazil S, et al. Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles. Bioorg Med Chem Lett 2013;23:6842-6
- Haydon DJ, Czaplewski LG, Palmer NJ, et al. Preparation of benzothiazole derivatives as antibacterial agents. US0004221; 2012
- Luniss CJ, Palmer JT, Pitt GRW, et al. Benzothiazole derivatives as antibacterial agents and their preparation. WO138860; 2013
- Lavoie EJ, Parhi A, Zhang Y, et al. Preparation of benzothiazole derivatives and related compounds as antimicrobial agents. WO142712; 2013
- Ding Z, Zhou W, Jiang J. Preparation of pyridothiazole and benzothiazole derivatives as antibacterial agents. CN103724360; 2014
- Guillemont JEG, Motte MMS, Koul A, Lounis N. Antimycobactrial compounds. WO096300; 2014
- Pellet A. Nitrobenzothiazole derivatives, their preparation, and their use in treating tuberculosis. WO069743; 2012
- Kamal A, Shetti RV, Swapna P, et al. Preparation of benzothiazole copounds as anti-tubercular agents. INDE02179; 2010
- Sheng C, Zhang W, Liu Y, et al. Substituted benzothiazoles as antifungal agents and their preparation, pharmaceutical compositions and use in the treatment of fungal infections. CN103193770; 2013
- Bayer CropScience AG. Cycloalkylamidobenzoxazoles and benzothiazoles as fungicides and their preparation and use for fighting harmful microorganisms in plants. EP2277869; 2011
- Bayer CropScience AG. Substituted benzoxazoles and benzothiazoles as fungicides and their preparation and use for fighting harmful microorganisms. EP2277870; 2011
- Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7
- Bellenie BR, Farre-Gutierrez I. Piperidine derivatives as microsomal prostaglandin E syntase-1 inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases. WO131975; 2011
- Dupont-Passelaigue E, Le RI, Pignier C. Preparation of N-[(4-substituted piperazin-1-yl)carbonyl]-heteroaryl sulfonamides and analogs as Kv potassium channel blockers. WO069503; 2012
- Aronov A, Come J, Cottrel K, et al. Preparation of benzothiazole derivatives for use as PI3K inhibitors and useful in the treatment of autoimmune diseases. WO135014; 2010
- Alder CM, Baldwin IR, Barton NP, et al. Preparation of 2-[2-(benzo- or pyrido-)thiazolylamino]-6-aminopyridine derivatives useful in the treatment of respiratory, allergic or inflammatory diseases. WO110575; 2011
- Mjalli AM, Polisetti DR, Kassis JN, et al. Substituted benzimidazole derivatives as HMOX1 modulators and their preparation and use for the treatment of inflammatory diseases. US0201604; 2011
- Wang A, Zhang Y, Leonard KA, et al. Preparation of tricyclic inhibitors of pro-matrix metalloproteinase activation. WO068211; 2012
- Martinez Gil A, Perez Fernandez DI. Gil Auso-Gontan, C et al. Preparation of substituted benzothiazoles as casein kinase 1 inhibitors for the treatment of human diseases. WO114825; 2014
- Dahl R, Lee AHY, Kho C, et al. Benzothiazole or benzoxazole compounds as SUMO activators. WO036242; 2014
- Cao J, Erb B, Fairhurst RA, et al. Preparation of benzothiazolone compounds as beta-2 adrenoceptor agonists. WO035047; 2013
- Rathod R, Bhatt T, Joshi K, et al. Preparation of quinoline, quinoxaline, or benzo[c]thiazole derivatives as cysteinyl leukotriene antagonists. WO051024; 2013
- Cui M, Liu B, Jia J. 2-Aryl benzothiazoles with high affinity to Ab plaque, preparation method and application thereof. CN103497217; 2014
- Zhang G, Wang S, Xu X, et al. Benzodioxane-benzoxazole (benzothiazole) piperidine derivatives and application thereof. CN103965186; 2014
- Jordan AD, Desjarlais RL, Hlasta DJ, et al. Preparation of substituted benzothiazole and benzoxazole derivatives useful as therapeutic inhibitors of DPP-1. WO075631; 2011
- Vu CB. Benzoxazoles and benzothiazoles as sirtuin modulators and their preparation, pharmaceutical compositions and use in the treatment of diabetes. WO019606; 2010
- Byrd CM, Dai D, Jordan R, et al. Treatment and prevention of dengue virus infections using 2-aryl-benzothiazoles and 2-heteroaryl-benzothiazoles. WO002635; 2011
- Yu J. Preparation of substituted benzothiazoles as TRPV1 antagonists. WO021276; 2013